|
JAMA Oncology |
Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors |
1 |
Yes |
4/22/2025 |
|
JAMA Dermatology |
Long-term Outcomes and Prognosis in New-Onset Psoriasis |
1 |
Yes |
6/16/2024 |
|
JAMA Neurology |
Long-term Risk of Parkinson Disease Following Influenza and Other Infections |
1 |
Yes |
12/9/2024 |
|
JAMA |
Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents |
1 |
Yes |
8/4/2024 |
|
JAMA |
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry |
1 |
Yes |
8/1/2026 |
|
JAMA Network Open |
Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic |
1 |
Yes |
10/26/2025 |
|
University of California, San Francisco, School of Medicine |
Lost in Transitions of Care: Managing an Opioid-Dependent Patient with Frequent Hospitalizations |
1 |
No |
9/29/2024 |
|
JAMA |
Lottery-Based Incentive in Ohio and COVID-19 Vaccination Rates |
1 |
Yes |
8/4/2024 |
|
JAMA |
Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia |
1 |
Yes |
6/1/2024 |
|
JAMA |
Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia - Review |
1 |
Yes |
6/1/2024 |
|
JAMA |
Lung Transplants for COVID-19: The Option of Last Resort |
1 |
Yes |
6/21/2024 |
|
JAMA Dermatology |
Lupus Miliaris Disseminatus Faciei |
1 |
Yes |
3/16/2025 |
|
JAMA Dermatology |
Lupus Pernio |
1 |
Yes |
2/16/2025 |
|
JAMA Ophthalmology |
Macular Fluid in a Patient With a Reported History of Normal-Tension Glaucoma |
1 |
Yes |
1/6/2025 |
|
JAMA Neurology |
Magnetic Resonance Imaging Features of Tropical Candidal Meningoencephalitis |
1 |
Yes |
3/14/2025 |
|
AMA Journal of Ethics |
Making Merit Just in Medical School Admissions |
1 |
Yes |
2/6/2027 |
|
JAMA Internal Medicine |
Malignant Anterior ST-Segment Elevation |
1 |
Yes |
4/4/2025 |
|
JAMA |
Management of Acne Vulgaris - A Review |
1 |
Yes |
11/23/2024 |
|
JAMA Oncology |
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors |
1 |
Yes |
1/20/2025 |
|
JAMA Oncology |
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors - A Systematic Review |
1 |
Yes |
1/20/2025 |
